The Aporia
AFP. (2026, September 20). Ebola vaccine being tested in DR Congo outbreak zone. The Hindu. https://www.thehindu.com/news/international/ebola-vaccine-being-tested-in-dr-congo-outbreak-zone/article71488850.ece
AFP. “Ebola vaccine being tested in DR Congo outbreak zone.” The Hindu, 20 Sept. 2026, https://www.thehindu.com/news/international/ebola-vaccine-being-tested-in-dr-congo-outbreak-zone/article71488850.ece.
AFP. “Ebola vaccine being tested in DR Congo outbreak zone.” The Hindu, September 20, 2026. https://www.thehindu.com/news/international/ebola-vaccine-being-tested-in-dr-congo-outbreak-zone/article71488850.ece.
Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.
On September 20, Congo began vaccinating healthcare staff in Bunia, the epicenter of the fastest-growing Ebola outbreak, with the Ervebo vaccine. The move prioritizes front-line workers who are particularly exposed and deeply involved in responding to the crisis. The current outbreak is caused by the Bundibugyo virus strain, for which there is no licensed vaccine or treatment, unlike the more common Zaire strain that Ervebo was developed against. Around 50,000 health and front-line workers across Ituri and North Kivu provinces will receive the vaccine in a study lasting up to one year, backed by the World Health Organization (WHO) and Médecins Sans Frontières (MSF). This vaccination campaign aims to assess Ervebo's effectiveness against the Bundibugyo strain.